| Members |
targetComponentId |
| [M]Aleukaemic monocytic leukaemia |
Monocytic leukaemia |
| [M]Angiofibroma NOS |
Angiofibroma (morphologic abnormality) |
| [M]Chronic leukaemia NOS |
Chronic leukemia |
| [M]Chronic monocytic leukaemia |
Chronic myeloid leukemia (morphologic abnormality) |
| [M]Haemangiopericytic neoplasms |
Solitary fibrous tumor |
| [M]Malignant melanoma NOS or melanocarcinoma or melanoma NOS |
Malignant melanoma |
| [M]Monocytic leukaemia NOS |
Monocytic leukaemia |
| [M]Other lymphoid leukaemia NOS |
Lymphoid leukaemia |
| [M]Plasmacytoma NOS |
Plasmacytoma (disorder) |
| [M]Subacute monocytic leukaemia |
Subacute leukaemia |
| [M]Subacute monocytic leukaemia |
Subacute leukaemia |
| [SO] uterus: [gravid] or [delivered] |
Uterine structure |
| [V]Examination for institution NOS |
Examination for institution (procedure) |
| [V]Other arthropod-borne viral disease vaccination |
Vaccination for arthropod-borne virus |
| [V]Screening for other arthropod-borne viral disease |
Viral screening |
| [V]Screening for other hemoglobinopathy |
Haemoglobinopathy screening test |
| [V]Screening for other inborn errors of metabolism |
Inborn errors of metabolism screen |
| [V]Screening for other specified parasitic infection |
Infection screening (procedure) |
| [X] (Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction) or (organic psychosyndrome) |
Organic mental disorder |
| [X] Mental and behavioural disorders due to use of opioids: withdrawal state (& [cold turkey, opiate withdrawal]) |
Opioid withdrawal |
| [X](Overeating associated with other psychological disturbances) or (psychogenic overeating) |
Psychogenic overeating |
| [X]Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified |
Abnormal findings on diagnostic imaging of skull and head |
| [X]Acute transmural myocardial infarction of unspecified site |
Postoperative myocardial infarction |
| [X]Acute transmural myocardial infarction of unspecified site |
Postoperative myocardial infarction |
| [X]Benign neoplasm of other parts of uterus |
Benign neoplasm of uterus |
| [X]Fracture of other parts of bony thorax |
Fracture of bone of thorax (disorder) |
| [X]Insertion of gastric or duodenal sound as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure |
Complication of procedure |
| [X]Measles with other complications |
Measles |
| [X]Megaloblastic anemia NOS |
Megaloblastic anemia |
| [X]Other bacterial diseases |
Bacterial infectious disease |
| [X]Other diseases of the respiratory system |
Disorder of respiratory system (disorder) |
| [X]Other diseases of the upper respiratory tract |
Disorder of upper respiratory system (disorder) |
| [X]Other disorders of skin and subcutaneous tissue in diseases classified elsewhere |
Disorder of skin and/or subcutaneous tissue (disorder) |
| [X]Other disorders of the skin and subcutaneous tissue |
Disorder of skin and/or subcutaneous tissue (disorder) |
| [X]Other leukemia of unspecified cell type |
Leukaemia |
| [X]Other retinal disorders in diseases classified elsewhere |
Retinal disorder |
| [X]Other specified bacterial diseases |
Bacterial infectious disease |
| [X]Other specified cerebrovascular diseases |
Cerebrovascular disease |
| [X]Other specified conditions originating in the perinatal period |
Perinatal disorder (disorder) |
| [X]Other specified diseases of pericardium |
Disorder of pericardium |
| [X]Other specified diseases of spinal cord |
Spinal cord disorder (disorder) |
| [X]Other specified diseases of upper respiratory tract |
Disorder of upper respiratory system (disorder) |
| [X]Other specified disorders of the central nervous system |
Disorder of the central nervous system (disorder) |
| [X]Other specified disorders of the skin and subcutaneous tissue |
Disorder of skin and/or subcutaneous tissue (disorder) |
| [X]Other specified disorders of tympanic membrane |
Disorder of tympanic membrane |
| [X]Other specified endocrine disorders |
Disorder of endocrine system |
| [X]Other specified hemorrhagic conditions |
Disorders involving the elements of blood coagulation, including platelets, coagulation factors and inhibitors, and the fibrinolytic system. |
| [X]Other specified retinal disorders |
Retinal disorder |
| [X]Secondary malignant neoplasm of other specified sites |
Metastatic malignant neoplasm (disorder) |
| [X]Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure |
Complication of procedure |
| [X]Varicose veins of other specified sites |
Venous varices (disorder) |
| alpha-Aminoacylpeptide hydrolase |
Alpha-aminoacylpeptide hydrolase (substance) |
| beta Carotene |
Betacarotene |
| cDE genotype |
cDE haplotype (finding) |
| cDe genotype |
cDe haplotype (finding) |
| cdE genotype |
cdE haplotype (finding) |
| cde genotype |
cde haplotype (finding) |
| de Quervain's disease |
Radial styloid tenosynovitis |
| bosted |
Residential home |
| e-mail konsultation |
E-mail consultation |
| retsmedicin |
Legal medicine (qualifier value) |
| kV |
kilovolt |
| lotrozole |
Product containing letrozole (medicinal product) |
| mA |
mA - milliampere |
| mV |
millivolt (qualifier value) |
| n-1-Naphthyl sodium salt |
Herbicide |
| p-Amino diphenylamine |
4-aminobiphenyl (substance) |
| fund vedr. pM-kategori |
American Joint Committee on Cancer pathological M category allowable value (qualifier value) |
| pM0-stadium |
American Joint Committee on Cancer cM0 (qualifier value) |
| pM0: Ingen fjernmetastase (mamma) |
American Joint Committee on Cancer cM0 (qualifier value) |
| pM1 (IV): Fjernmetastase (TNM-kategori og FIGO-stadium) (tuba uterina) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IV): Fjernmetastase (TNM-kategori og FIGO-stadium) (ovarium) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IVB): Fjernmetastase (TNM-kategori og FIGO-stadium) (corpus uteri) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IVB): Fjernmetastase (TNM-kategori og FIGO-stadium) (cervix uteri) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IVB): Fjernmetastase (TNM-kategori og FIGO-stadium) (vagina) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IVB): Fjernmetastase (inklusive metastasering til lymfeknuder i pelvis) (TNM-kategori og FIGO-stadium) (vulva) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1-stadium |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1: Fjernmetastase (mamma) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1: fjernmetastase i lunge inklusive separat(e) tumornodulus(noduli) i en anden lobus ipsilateralt eller kontralateralt |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1a (III): Tumor med spredning til lungerne med eller uden involvering af tractus genitalis (TNM-kategori og FIGO-stadium) (gestationel trofoblast) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a-stadium |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Fjernmetastase (oesophagus) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Fjernmetastase ikke fastslået (midttorakale oesophagus) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Fjernmetastase til knoglemarven (retinoblastom) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: fjernmetastase til lunge (knogle) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Fjernmetastase til lunge (primitiv neuroektodermal tumor/Ewings sarkom) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Fjernmetastase til ikke-regional(e) lymfeknude(r) (prostata) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Metastasering til lymfeknuder i bughulen (nedre torakale oesophagus) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: metastasering til cervikale lymfeknuder (øvre torakale oesophagus) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Metastasering til hud, subkutant væv eller fjerne lymfeknuder (hudmelanom) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Ikke-regional nodal eller pulmonal metastase (testis) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1b (IV): Fjernmetastase til andet end lungen (TNM-kategori og FIGO-stadium) (gestationel trofoblast) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b-stadium |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Fjernmetastase (oesophagus) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Fjernmetastase til andet end ikke-regionale lymfeknuder og lunger (testis) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Fjernmetastase til knogle(r) (prostata) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Fjernmetastase til anden lokalisation end lymfeknuder i bughulen (nedre torakale oesophagus) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: fjernmetastase til anden lokalisation end cervikale lymfeknuder (øvre torakale oesophagus) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: fjernmetastase til anden lokalisering end lunge (knogle) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Fjernmetastase til anden lokalisation end lungen (primitiv neuroektodermal tumor/Ewings sarkom) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Fjernmetastase til andre lokalisationer end knoglemarven (retinoblastom) |
American Joint Committee on Cancer pM1b (qualifier value) |
FHIR